Merck & Co. Inc. (MRK)

$ 147.15
   
  • Change Today:
    $2.24
  • 52 Week High: $156.45
  • 52 Week Low: $77.60
  • Currency: US Dollars
  • Shares Issued: 2,474.63m
  • Volume: 11,063,793
  • Market Cap: $364,141m
  • RiskGrade: 92

Latest ShareCast News

Moderna, MSD hail positive trial results for melanoma vaccine

By Michele Maatouk

Date: Friday 21 Aug 2026

(Sharecast News) - Pharmaceutlcal firms Moderna and MSD (Merck Sharp & Dohme (UK) Limited) said on on Wednesday that a personalised mRNA melanoma vaccine they are jointly developing had shown positive results in a first-ever late-stage trial.

Merck News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Merck Market Data

Currency US Dollars
Share Price $ 147.15
Change Today $ 2.24
% Change 1.55 %
52 Week High $156.45
52 Week Low $77.60
Volume 11,063,793
Shares Issued 2,474.63m
Market Cap $364,141m
RiskGrade 92

What The Brokers Say

Strong Buy 8
Buy 12
Neutral 7
Sell 0
Strong Sell 0
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 17-Sep-2026

Time Volume / Share Price
16:03 3,038,309 @ $147.15
15:59 400 @ $147.17
15:59 400 @ $147.17
15:59 100 @ $147.17
15:59 100 @ $147.17

Top of Page